During the past decade, Radiant Research, Inc conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 67 clinical trials were completed, i.e. on average, 108.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 40 clinical trials were completed. i.e. 235.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiant Research, Inc" #1 sponsor was "Pfizer" with 16 trials, followed by "Allergan" with 10 trials sponsored, "Shire" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiant Research, Inc" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Cognitive Research Corporation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Radiant Research, Inc" are "Atopic Dermatitis" (7 trials), "Osteoarthritis" (7 trials), "Psoriasis" (6 trials), "Binge Eating Disorder" (5 trials) and "Hyperlipidemia" (5 trials). Many other conditions were trialed in "Radiant Research, Inc" in a lesser frequency.

Most popular intervention types in "Radiant Research, Inc" are "Drug" (111 trials), "Biological" (14 trials), "Other" (7 trials), "Device" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "Relamorelin" (4 trials), "Diclofenac" (3 trials), "Vehicle" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Radiant Research, Inc" are 120 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Radiant Research, Inc". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Radiant Research, Inc, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Radiant Research, Inc, 2 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".